The top three health threats facing the people of Zimbabwe are HIV, tuberculosis (TB), and malaria. These diseases contribute significantly to maternal and childhood illness and deaths. Declining economic conditions and rising costs of living have eroded a health system once known regionally for its well-educated, robust workforce and ability to provide advanced medical care. USAID supports programs to reduce preventable deaths and lessen the disease burden, especially among women and children under five.
HIV and AIDS
USAID’s HIV prevention, care and treatment activities under the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) have contributed to the great successes achieved under the national AIDS program. Since PEPFAR’s inception in Zimbabwe in 2006, the annual number of HIV-related deaths has declined by 80 percent. AIDS-related deaths have fallen from 121,000 in 2005 to 24,000 in 2017. Although the number of AIDS-related deaths continues to decrease, HIV prevalence in Zimbabwe remains high.
In 2019, PEPFAR contributed more than $160 million for HIV prevention, treatment, care and support activities in Zimbabwe. This investment has resulted in more than 960,000 Zimbabweans being put on lifesaving antiretroviral medicines (ARVs) to date.
More than 90 percent of all antenatal care sites in Zimbabwe have PEPFAR-supported services for the prevention of mother-to-child transmission of HIV, allowing pregnant women who test positive for HIV to initiate lifelong antiretroviral therapy, saving the lives of newborns.
In 2016, the U.S. Government launched a $60 million initiative in six districts in Zimbabwe to reduce new HIV infections among adolescent girls and young women. The initiative, called DREAMS, helps more than 476,000 girls live Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe lives.
Annually, the United States provides substantial HIV prevention, treatment, care, and support through PEPFAR to:
- Provide voluntary medical male circumcision for over 200,000 men;
- Support HIV testing and counseling for over 2 million people;
- Support community level interventions that care for orphans and vulnerable children infected or affected by HIV, improving the well-being of over 307,000 children; and
- Support HIV prevention, treatment, care, and support among adolescent girls and young women and key populations, including sex workers.
USAID supports the national tuberculosis (TB) control programme to prevent, find and detect, and treat TB cases across Zimbabwe. TB is the second leading cause of death in Zimbabwe, and many cases are drug resistant. USAID support has helped the TB program detect 78 percent of the cases, initiate 91 percent of the cases on treatment, and successfully treat 85 percent of all TB patients.
USAID supports universal testing of patients for TB and HIV, rollout of newer and shorter TB treatment regimens for patients with drug resistant TB, and refurbishment of national TB reference laboratories. USAID also supports a robust sample transport system, which serves more than 900 of the 1,500 health facilities nationwide, drastically reducing turn-around time and increasing the number of specimens collected and tested. Patients with HIV and TB have seen a 75 percent reduction in HIV-associated TB mortality between 2016 and 2018, and Zimbabweans affected by TB now live longer and healthier lives.